Higher antidepressant dose may be risky for seniors with kidney issues
NCT ID NCT07399795
First seen Feb 16, 2026 · Last updated May 17, 2026 · Updated 9 times
Summary
This study examined the safety of starting citalopram at 20 mg/day versus 10 mg/day in adults aged 65 and older with reduced kidney function. Researchers analyzed health records from over 7,000 participants to see if the higher dose increased the risk of hospitalization, emergency visits, or death within 30 days. The goal was to gather knowledge on medication risks, not to provide treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (CKD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
London Health Sciences Centre Research Institute
London, Ontario, Canada
Conditions
Explore the condition pages connected to this study.